J. Oldhoff

Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

J. Ring, U. Darsow, E. Knol, 2005, Allergy.

In vivo evaluation of therapeutic options in atopic dermatitis

J. Oldhoff, J. M. Oldhoff, 2006 .

No Effect of Anti-Interleukin-5 Therapy (Mepolizumab) on the Atopy Patch Test in Atopic Dermatitis Patients

J. Ring, M. D. de Bruin‐Weller, U. Darsow, 2006, International Archives of Allergy and Immunology.

Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population

M. Schuttelaar, J. Oldhoff, L. Loman, 2022, Clinical and experimental dermatology.

Dupilumab in a child with severe atopic dermatitis and severe asthma—a rare case with severe limbitis and exercise‐induced anaphylaxis

M. Schuttelaar, I. Bocca-Tjeertes, J. Oldhoff, 2022, International journal of dermatology.

Atopy patch test in patients with atopic eczema/dermatitis syndrome: comparison of petrolatum and aqueous solution as a vehicle

E. Knol, C. Bruijnzeel‐Koomen, M. Bruin-Weller, 2004, Allergy.

Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%

E. Knol, C. Bruijnzeel‐Koomen, M. Bruin-Weller, 2006, Allergy.